Glancy Prongay & Murray LLP Commences Investigation on Behalf of Amyris, Inc. Investors
Glancy Prongay & Murray LLP (“GPM”) is investigating potential claims on behalf of investors of Amyris, Inc.
(“Amyris” or the “Company”) (NASDAQ: AMRS) concerning the Company and its officers’ possible violations of federal securities laws.
On April 17, 2017, Amyris disclosed revenues of $67.2 million for fiscal year 2016, a decrease of $10 million from the figures
it released on March 2, 2017 and April 3, 2017. According to Amyris, the surprising $10 million decrease resulted from the
Company’s decision in the first quarter of 2017 to take an equity stake in Blue California’s affiliates, and therefore not
recognize certain revenues from the license agreement with Blue California.
On this news, shares of Amyris fell over 14% to close at $0.60 per share on April 18, 2017.
If you purchased Amyris securities, have information or would like to learn more about these claims, or have any questions
concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles, California 90067 at
310-201-9150, Toll-Free at 888-773-9224, by email to shareholders@glancylaw.com, or visit our website at http://www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and
number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Glancy Prongay & Murray LLP, Los Angeles
Lesley Portnoy, 310-201-9150 or 888-773-9224
shareholders@glancylaw.com
www.glancylaw.com
View source version on businesswire.com: http://www.businesswire.com/news/home/20170504005613/en/